Dermatologists' knowledge of and preferences regarding topical steroids

Journal of Drugs in Dermatology

Volumn 12, Issue 7, 2013, Pages 786-789

  Sandoval, Laura F ^a   Davis, Scott A ^a   Feldman, Steven R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE DIPROPIONATE; BETAMETHASONE VALERATE; BUTYRIC ACID; CLOBETASOL PROPIONATE; CLOCORTOLONE; CLOCORTOLONE PIVALATE; CORTICOSTEROID; DESONIDE; DESOXIMETASONE; DIFLORASONE DIACETATE; FLUOCINOLONE; FLUOCINOLONE ACETONIDE; FLUOCINONIDE; FLUTICASONE PROPIONATE; HYDROCORTISONE; HYDROCORTISONE BUTYRATE; HYDROCORTISONE VALERATE; TACROLIMUS; TRIAMCINOLONE ACETONIDE; ULOBETASOL PROPIONATE; VALERIC ACID;

ALLERGENICITY; ARTICLE; DERMATOLOGIST; DRUG HYPERSENSITIVITY; DRUG POTENCY; DRUG PREFERENCE; HEALTH CARE QUALITY; HEALTH CARE SURVEY; HUMAN; PRESCRIPTION; PROFESSIONAL KNOWLEDGE;

ADMINISTRATION, CUTANEOUS; DERMATOLOGIC AGENTS; DERMATOLOGY; GLUCOCORTICOIDS; HEALTH CARE SURVEYS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; SKIN DISEASES; UNITED STATES;

EID: 84879900945     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Stern RS. The pattern of topical corticosteroid prescribing in the United States 1989-1991. J Am Acad Dermatol. 1996 Aug;35:183-186.
2. Hamilton RJ. Tarascon Pharmacopoeia 2011 Library Edition. Sudbury, MA: Jones and Barlett Learning; 2011:147-150.
3. Mackenzie AW. Method for comparing percutaneous absorption of steroids. Arch Dermatol. 1964;86:608-610.
4. Tadicherla S, Ross K, Shenefelt PD, et al. Topical corticosteroids in dermatology. J Drugs Dermatol. 2009 Dec;8(12):1093-105.
5. Housman TS, Mellen BG, Rapp SR, et al. Patients with psoriasis prefer solution and foam vehicles: a quantitative assessment of vehicle preference. Cutis. 2002 Dec;70(6):327-32. (Pubitemid 41757440)
6. Drake LA, Dinehart SM, Farmer ER, et al. Guidelines of care for the use of topical glucocorticosteroids. J Am Acad Dermatol. 1996;35:615-619. (Pubitemid 26427069)
7. Cole J, Zirwas MJ. Allergens in corticosteroid vehicles. Dermatitis. 2008 Jan-Feb;19(1)38-42. (Pubitemid 351428410)
8. Tempark T, Phatarakijnirund V, Chatproedprai S, et al. Exogenous Cushing's syndrome due to topical corticosteroid application: case report and review literature. Endocr. 2010;38:328-334.
9. Gonul M, Gul U. Detection of contact hypersensitivity to corticosteroids in allergic contact dermatitis patients who did not respond to topical corticosteroids. Contact Dermatitis. 2005;53:67-70. (Pubitemid 41039714)
10. Dooms-Goossens A, Anderson KE, Brandao FM et al. Corticosteroid contact allergy: an EECDRG multicentre study. Contact Dermatitis. 1996;35:40-44. (Pubitemid 26332044)
11. Burder AD, Beck MH. Contact hypersensitivity to topical corticosteroids. Br J Dermatol. 1992 Nov;127(5):497-500.
12. Lee, J, Warshaw E, Zirwas M. Allergens in the American Contact Dermatitis Society Core Series. Clin Dermatol. 2011 May-Jun;29(3):266-272.
13. Baeck M, Goossens A. Immediate and delayed allergic hypersensitivity to corticosteroids: practical guidelines. Contact Dermatitis. 2012 Jan;66(1)38-41.
14. Balkrishnan R, Camacho FT, Pearce DJ et al. Factors affecting prescriptions of ultra-high potency topical corticosteroids in skin disease: an analysis of US national practice data. J Drugs Dermatol. 2005 Nov-Dec;4(6):699-706.
15. Saraswat A, Lahiri K, Chatterjee M et al. Topical corticosteroid abuse on the face: A prospective, multicentre study of dermatology outpatients. Indian J Dermatol Venereol Leprol. 2011;77:160.
16. Topicort [package insert]. Hawthorne, NY: Taro Pharmaceuticals USA Inc; 2011.
17. Cloderm [package insert]. Bridgewater, NJ: Promius Pharma, LLC; 2011.
18. Baeck M, Chemelle JA, Rasse C et al. C(16)-methylated corticosteroids are less allergenic than the non-methylated molecules. Contact Dermatitis. 2011;64(6):305-312.
19. Davis MD, el-Azhary RA, Farmer SA. Results of patch testing to a corticosteroid series: a retrospective review of 1188 patients during 6 years at Mayo Clinic. J Am Acad Dermatol. 2007 Jun;56(6):921-927 (Pubitemid 46720208)
20. Protopic [package insert]. Deerfield, IL: Astellas Pharma US, Inc; 2011.
21. Shaw DW, Eichenfield LF, Shainhouse T et al. Allergic contact dermatitis from tacrolimus. J Am Acad Dermatol. 2004;50:962-965. (Pubitemid 38685783)
22. Shaw DW, Maibach HI, Eichenfield LF. Allergic contact dermatitis from pimecrolimus in a patient with tacrolimus allergy. J Am Acad Dermatol. 2007;56:342-345. (Pubitemid 46074259)
23. Schmutz JL, Barbaud A, Trechot P. Contact allergy with tacrolimus them pimecrolimus. Ann Dermatol Venerol. 2008;135:89. (Pubitemid 351970358)